T cells with dysfunctional mitochondria induce multimorbidity and premature senescence.

The effect of immunometabolism on age-associated diseases remains uncertain. In this work, we show that T cells with dysfunctional mitochondria owing to mitochondrial transcription factor A (TFAM) deficiency act as accelerators of senescence. In mice, these cells instigate multiple aging-related fea...

ver descrição completa

Detalhes bibliográficos
Autores: Desdín-Micó, Gabriela, Soto-Heredero, Gonzalo, Aranda, Juan Francisco, Oller, Jorge, Carrasco, Elisa, Gabandé-Rodríguez, Enrique, Blanco, Eva Maria, Alfranca, Arantzazu, Cusso, Lorena, Desco, Manuel, Ibáñez, Borja, Gortazar, Arancha R, Fernández-Marcos, Pablo, Navarro, Maria N, Hernaez, Bruno, Alcamí, Antonio, Baixauli, Francesc, Mittelbrunn, María
Formato: artículo
Fecha de publicación:2020
País:España
Recursos:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/10721
Acesso em linha:http://hdl.handle.net/20.500.12105/10721
Access Level:acceso abierto
Descrição
Resumo:The effect of immunometabolism on age-associated diseases remains uncertain. In this work, we show that T cells with dysfunctional mitochondria owing to mitochondrial transcription factor A (TFAM) deficiency act as accelerators of senescence. In mice, these cells instigate multiple aging-related features, including metabolic, cognitive, physical, and cardiovascular alterations, which together result in premature death. T cell metabolic failure induces the accumulation of circulating cytokines, which resembles the chronic inflammation that is characteristic of aging ("inflammaging"). This cytokine storm itself acts as a systemic inducer of senescence. Blocking tumor necrosis factor-α signaling or preventing senescence with nicotinamide adenine dinucleotide precursors partially rescues premature aging in mice with Tfam-deficient T cells. Thus, T cells can regulate organismal fitness and life span, which highlights the importance of tight immunometabolic control in both aging and the onset of age-associated diseases.